Results on Novartis prostate cancer therapy could expand its use

Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET.

STAT’s reporters, strung-out from several days of ASCO madness, will take the virtual stage to share convention hall insights, predictions for the months ahead, and of course will take your audience questions live.

advertisement

Sponsor Introduction

• Ashwin Athri, EVP, strategy, innovation, & partnerships, Precision AQ

Featured Speakers

• Angus Chen, cancer reporter, STAT
• Adam Feuerstein, senior writer, biotech, STAT
• Matthew Herper, senior writer, medicine; editorial director of events, STAT
• Katherine MacPhail, programmer, editorial events, STAT (moderator)

Sponsored By